JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A5331 TSU-68 (SU6668,Orantinib)

Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive

insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL
A5478 AZD6482

Target: PI3K

Summary: PI3Kβ inhibitor,potent and selective

insoluble in H2O; ≥20.4 mg/mL
A5793 Quizartinib (AC220)

Target: FLT3

Summary: FLT3 inhibitor,potent and selective

≥28.03 mg/mL
A8316 PD 0332991 (Palbociclib) HCl
15 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor

≥14.48 mg/mL
A8337 CX-5461
7 Citation

Summary: Pol I-mediated rRNA synthesis inhibitor

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
A8374 AZD8330

Target: MEK

Summary: MEK 1/2 inhibitor

≥23.05 mg/mL
A8523 Sodium 4-amiropparaty Hyalrate

Summary: Sodium 4-amiropparaty Hyalrate
A8532 Teniposide

Summary: Topoisomerase inhibitor

≥23.65 mg/mL
A9902 Bcl Family Set I

Summary: Bcl family inhibitors
B1622 SGI-1027
4 Citation

Summary: DNMT inhibitor

≥22.25 mg/mL